Date: May 27-29, 2026
Location: Charlotte Convention Center, NC
Booth: #756
Bioness Medical is excited to exhibit at this year’s Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting. Stop by our Booth# 756 to learn how PoNS Therapy® and the broader Bioness portfolio of innovative rehabilitation technology, such as the L300 Go Foot Drop System are helping people improve mobility and stay active.
No serious adverse events related to the PoNS device were reported in the MS RCTs or in use in clinical rehabilitation settings to treat balance and gait disorders.
Some individuals have reported headaches, fatigue, and excess salivation. Excess salivation during training sessions often occurs but generally improves as patients get used to wearing the mouthpiece.
Indication
The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.
Contraindications
The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).
Electrical stimulation should not be used:
The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.
Use with caution
Electrical stimulation should only be used after seeking professional medical advice, and with caution in patients with any of the following: